A Brazilian Case of Treatment-Resistant Generalized Anxiety Disorder Successfully Treated with Monoamine Oxidase Inhibitor (MAOI)

Psychiatr Danub. 2020 Sep;32(Suppl 1):139-141.

Abstract

In this brief report we present the case of a 53 year old man with a very debilitating Generalized Anxiety Disorder successfully treated with tranylcypromine. After several failed treatment attempts following international guidelines recommendations over the course of one year and a half, tranylcypromine was prescribed which led to effective and sustained remission of anxiety symptoms for this patient. We also briefly explore treatment options for resistant cases of generalized anxiety disorder, given the major negative impacts of untreated GAD in a person's daily functioning and quality of life.

Publication types

  • Case Reports

MeSH terms

  • Anxiety
  • Anxiety Disorders* / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase Inhibitors* / therapeutic use
  • Quality of Life*

Substances

  • Monoamine Oxidase Inhibitors